NIH-funded research R01 grant

Closed-loop control of interneuron timing to influence seizures and memory in epilepsy

Official title: Closed-loop Control of Interneuron Spike Timing in Epilepsy

Funded at Icahn School of Medicine at Mount Sinai · NIH-11617814 · Data updated 2026-11-12

A study tests a brain-quieting system that uses light to precisely time certain brain cells in epilepsy-prone mice to see if this can lessen seizures and improve memory.

More Epilepsy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startMarch 1, 2024
Project endFebruary 28, 2029
Funding year2026
Award (this year)$112,791
NIH project number3R01NS136590-03S1
Project IDNIH-11617814 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with temporal lobe epilepsy or related cognitive impairments who might benefit from therapies targeting interneuron timing.

Less likely to help

Patients without temporal lobe epilepsy or without cognitive concerns related to seizures may not benefit from this research.

What this research studies

Researchers will use a novel closed-loop optogenetic system in mice with temporal lobe epilepsy to control when specific interneurons fire during behavior. By shifting the theta-phase locking of parvalbumin- or somatostatin-expressing interneurons, they will observe effects on seizure susceptibility and cognitive performance. In healthy mice, they will impose abnormal timing to see if it worsens seizures or memory, while in epileptic mice they will normalize timing to test for seizure reduction and memory rescue. The goal is to understand whether interneuron timing directly drives epileptic symptoms and associated cognitive deficits. Findings could guide future strategies to modulate brain activity to reduce seizures and cognitive impairment in epilepsy.

Why it matters

Potential benefit: If successful, this work could lead to new approaches that reduce seizures and preserve memory in people with temporal lobe epilepsy.

How similar studies have gone: Previous animal studies using optogenetic timing have shown that altering interneuron activity can modify seizure-like activity, supporting potential translational relevance.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Shuman, Tristan — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Shuman, Tristan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.